NCT02246855View on ClinicalTrials.gov

A Comparison of the Pharmacokinetics, Safety and Tolerance of Two Formulations of a Liquid IVIg in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 2004

Primary Completion Date

December 31, 2004

Conditions
Healthy
Interventions
BIOLOGICAL

Gammaplex® (Human Normal Immunoglobulin)

Trial Locations (1)

HA1 3UJ

Clinical Pharmacology Research Unit (CPRU), Level 7, Northwick Park Hospital

Sponsors
All Listed Sponsors
lead

Bio Products Laboratory

OTHER